Peloton Equity is a newly-formed private equity firm that focuses exclusively on growth capital investing in the lower middle market of the healthcare industry. Peloton seeks to invest $15-30MM per company, and has the ability to invest more with co-investments. Peloton is the growth capital investment team spun-out of Ferrer Freeman & Company, which has over 40 years of combined investing experience. Peloton leverages its extensive healthcare network, value-building diligence and investment process, and portfolio management playbook to add value to its portfolio companies.
10
Total Investments
6
Portfolio Companies
-
Exits
2
Industries
General Information
Industries
Health Care, Pharmaceutical
Company Overview
Investment Criteria
Investment Thesis
•••••• •••••• ••••••
About Peloton Equity
Recent Investments (10)
View All| Company | Stage | Amount | Date |
|---|---|---|---|
| Private Equity Round | •••••• | Jan 2024 | |
| Private Equity Round | •••••• | Aug 2023 | |
| Private Equity Round | •••••• | May 2022 | |
| Venture Round | •••••• | Sep 2020 | |
| Series B | •••••• | Feb 2020 | |
|
|
Private Equity Round | •••••• | Oct 2019 |
|
|
Venture Round | •••••• | Jul 2019 |
|
|
Venture Round | •••••• | Jan 2017 |
|
|
Venture Round | •••••• | Aug 2016 |
|
|
Private Equity Round | •••••• | Apr 2015 |
All startup & investor data, one platform.
Filter investors by stage, sector, and geography. Compare portfolios side by side. Spot market signals before anyone else.